Eli Lilly and Co NEW YORK STOCK EXCHANGE, INC.:LLY
The leadership team, board of directors, and 10% beneficial owners of Eli Lilly and Co, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
Alvarez Ralph
—758 sharesBertozzi Carolyn R
—2,000 sharesDozier Eric
—385.02 sharesHakim Anat
—15,700 sharesHedley Mary Lynne
—98 sharesHernandez Edgardo
—871.35 sharesJonsson Patrik
—611.2 sharesRicks David A
—68,656 sharesSkovronsky Daniel
—72,359 sharesVan Naarden Jacob
—4,342 sharesZakrowski Donald A
—1,728.57 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.